AzTrials
AzTrials

Gingival RecessionADMNCT03392038

Thick vs. Thin Acellular Dermal Matrix (ADM)

A study testing Thin ADM and Thick ADM in people with Gingival Recession, run by University of Louisville at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To study and compare a thick vs thin acellular dermal matrix for root coverage using the coronally positioned tunnel technique. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Gingival Recession
What is being tested?
Thin ADM and Thick ADM
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteUnited States
Study dates
30 Nov 2017to 21 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least one Miller Class I or II mucogingival defect ≥ 3 mm (Miller 1985). B. The mucogingival defect must be on a non-molar tooth. C. Patients must be ≥ 18 years of age.

Who cannot join

  • Patients with debilitating systemic or diseases that significantly affect the periodontium.
  • Patients with a known allergy to any of the materials that will be used in the study, including systemic antibiotics (tetracycline and doxycycline).
  • Patients requiring antibiotic prophylaxis. D. Root surface restorations at the site of recession. E. No detectable CEJ F. Patients who fail to maintain acceptable oral hygiene levels at the test and adjacent teeth.
  • Patients who are pregnant or lactating. H. Patients who use tobacco products (smoking or smokeless tobacco). I. Patients with alcohol abuse problems. J. Patients undergoing long-term steroid therapy. K. History of previous root coverage procedures, graft or GTR, on the test teeth.
  • Patients who fail to complete the informed consent form.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Graduate Periodontics, UofL School of Dentistry

    Louisville, Kentucky, 40202

Other trials in United States

About this study

Official title: Root Coverage Using the Coronally Positioned Tunnel Technique Comparing Thick Versus Thin Acellular Dermal Matrix

To study and compare a thick vs thin acellular dermal matrix for root coverage using the coronally positioned tunnel technique.

Being tested
Thin ADM, Thick ADM
Medical subject headings
Gingival Recession

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thin ADMProcedure or surgery

    Also called Thin acellular dermal matrix (ADM GBR)

    Use of soft tissue allograft for root coverage

  • Thick ADMProcedure or surgery

    Also called Thick acellular dermal matrix graft (ADM)

    Periodontal surgical procedure to coronally position the tissue over the ADM allograft

Study groups in NCT03392038
Study groupRoleWhat they receive
Thin ADMExperimentalPeriodontal root coverage surgery using a coronally positioned tunnel and thin acellular dermal matrix (ADM GBR)
Receives: Procedure: Thin ADM
Thick ADMActive comparatorPeriodontal root coverage surgery using coronally positioned tunnel surgery and thick acellular dermal matrix graft (ADM)
Receives: Procedure: Thick ADM

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent root coverage

    Between 0 and 100%

    Measured: Six months

Secondary outcomes (1)
  1. Creeping Attachment

    Amount in millimeters

    Measured: Six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2018
  2. Study start30 Nov 2017
  3. Primary completion21 Aug 2018
  4. Study completion21 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03392038
Sponsor's protocol ID
16.0462
Acronym
ADM
Status last verified
Sep 2020
First submitted
31 Dec 2017
Last updated
10 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Thin ADM and Thick ADM in people with Gingival Recession, run by University of Louisville at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent root coverage (time frame: Six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Thick vs. Thin Acellular Dermal Matrix (ADM) | AzTrials